Philipp M. Roessner, MD

About

Physician-scientist working at the intersection of translational medicine, drug development strategy, and pharma & biotech innovation. My work focuses on bridging mechanistic immunology with therapeutic innovation, biomarker-driven development, and precision medicine approaches in oncology and immune-mediated diseases. I have experience spanning translational research, immunotherapy, hematologic malignancies, scientific communication, and cross-functional collaboration in global R&D environments. Particularly interested in the strategic interface between translational science, clinical innovation, and emerging biotech ecosystems.

Experience

• Early Drug Developer (Oncology & MASH) at Boehringer Ingelheim
  Mar 2023 - Present · 3 yrs 4 mos

  Responsible and accountable for the design and conduct of FiH-studies in oncology and Ph2a proof of clinical principle studies in MASH.

• Associate Lecturer at Rosenheim Technical University of Applied Sciences
  Oct 2025 - Present · 9 mos

  Lecturer in Fundamentals of Applied Anatomy and Physiology, General Pathology, and Public Health for students of physiotherapy

• DKFZ German Cancer Research Center (8 yrs)
  • Postdoctoral Research Fellow (Leukemia and Lymphoma)
    Jun 2019 - Mar 2023 · 3 yrs 10 mos

  • M.D. Thesis (Dr. med.)
    Apr 2015 - Nov 2019 · 4 yrs 8 mos

• Lab Intern at MD Anderson Cancer Center
  Sep 2018 - Dec 2018 · 4 mos

  Analyzed the impact of clinical BTK inhibition on T-cell function and T-bet expression in CLL cells.